News

Cypralis Limited announces collaboration with Johnson & Johnson Innovation in the field of neurodegenerative diseases

Mon, 07/12/2015 - 09:00

University of Edinburgh and Selcia Achieve Key Milestones in Bid to Develop New Drugs to Target Sleeping Sickness

Mon, 30/11/2015 - 09:00

MedTech Engine – Jump-Starting Europe’s Medical Device Sector

Tue, 24/11/2015 - 11:30

Coming Soon to Big Pharma: Disruptive Innovation

Thu, 19/11/2015 - 16:15

Desktop Genetics Partners with Transcriptic Inc

Thu, 05/11/2015 - 17:00

Sigma-Aldrich Collaborates with GENEWIZ and Oxford Genetics to Speed Ordering Process for DNA Services

Wed, 04/11/2015 - 13:00

SynbiCITE to Lead UKTI Trade Mission to SynBioBeta San Francisco 2015

Tue, 03/11/2015 - 15:00

Selcia Working with Cypralis to Generate New Class of Selective Cyclophilin D Inhibitors

Mon, 02/11/2015 - 09:00

Canbex Therapeutics Announces Start of Phase II Trial of VSN16R for Spasticity

Mon, 02/11/2015 - 07:00

Domainex Announces Expansion of Its Service Business with a Move to New Research Building with Larger Facilities

Thu, 29/10/2015 - 09:00

Pages